Direct oral anticoagulant agents might be safe for patients undergoing endovenous radiofrequency and laser ablation

Heepeel Chang,Mikel Sadek,Michael E Barfield,Caron B Rockman,Thomas S Maldonado,Neal S Cayne,Todd L Berland,Karan Garg,Glenn R Jacobowitz

Journal of Vascular Surgery: Venous and Lymphatic Disorders（2023）

引用 2|浏览13

暂无评分

摘要

In our study of patients who had undergone ETA for symptomatic saphenous venous reflux, the periprocedural use of DOACs did not adversely affect the efficacy of endovenous ablation to ≥9 months. Furthermore, DOAC use did not confer an additional risk of bleeding, DVT, or EHIT periprocedurally. DOACs may be safely continued without affecting the efficacy and durability of ETA.

查看译文

关键词

Anticoagulation,Direct oral anticoagulants,Endovenous laser ablation,Endovenous thermal ablation,Radiofrequency ablation,Recanalization,Superficial venous reflux

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要